Compare AEON & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEON | AUST |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0M | 13.3M |
| IPO Year | 2021 | 2021 |
| Metric | AEON | AUST |
|---|---|---|
| Price | $0.23 | $0.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $1.82 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 57.2K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.71 |
| 52 Week High | $1.45 | $3.92 |
| Indicator | AEON | AUST |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 31.70 |
| Support Level | $0.24 | N/A |
| Resistance Level | $0.33 | $1.43 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 13.30 | 26.85 |
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Austin Gold Corp is focused on the acquisition, exploration, and evaluation of mineral resource properties in the western United States of America (USA). The exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek, Lone Mountain, Stockade Mountain, Fourmile Basin, and Miller.